High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

Area of Science:

• Biochemistry
• Nanotechnology
• Cardiovascular Medicine

Background:

• High-density lipoproteins (HDL) are endogenous nanoparticles crucial for cholesterol transport and metabolism.
• HDL possesses "good" cholesterol properties, removing plaque and exhibiting anti-inflammatory and antioxidative effects, thus protecting the cardiovascular system.
• HDL also transports vital biomolecules like proteins, vitamins, hormones, and microRNA to target organs.

Purpose of the Study:

• To review the clinical pharmacokinetics and safety of reconstituted HDL products.
• To compare HDL nanoparticles with inorganic and other organic synthetic nanocarriers.
• To highlight the potential of reconstituted HDL as a nanocarrier for targeted delivery.

Main Methods:

• Literature review focusing on clinical studies of reconstituted HDL.
• Comparative analysis of HDL properties against synthetic nanocarriers (liposomes, micelles, inorganic/polymeric nanoparticles).
• Evaluation of recombinant ApoA proteins and ApoA mimetic peptides in reconstituted HDL preparation.

Main Results:

• HDL nanoparticles exhibit unique advantages over synthetic nanocarriers, including ultrasmall size (8-12 nm), high human tolerability (up to 8 g/infusion), and long half-life (12-24 h).
• HDL possesses intrinsic targeting capabilities for various recipient cells.
• Reconstituted HDL, prepared using recombinant ApoA proteins or mimetic peptides, demonstrates properties similar to endogenous HDL and scalability for industrial production.

Conclusions:

• Reconstituted HDL represents a promising nanocarrier with superior characteristics compared to synthetic alternatives.
• Its safety, tolerability, and targeting efficiency support its potential in therapeutic applications.
• Further research into clinical pharmacokinetics and safety is essential for advancing reconstituted HDL products.